By
Sofia Sokolove in
May | June 2021 on
May 4, 2021 at 10:04 am |
No Comments
It occurs to me that you’ve now had a full year of Alcalde letters from me that muse about “the new normal” and the changes in every aspect of our lives the alumni association experience being chief among them.
Even with all the disruption, we managed to bring fellowship and enrichment to Longhorns everywhere through virtual events at the Texas Exes. I want to thank the Longhorns too many to name who stepped up to help make this virtual Texas Exes programming so meaningful and valuable. Some of it we will keep forever, as it has connected our network in new and exciting ways.
E-Mail
IMAGE: An analysis of blood plasma samples from four people who recovered from SARS-CoV-2 infectionsshows that most of the antibodies circulating in the blood on average, about 84% target. view more
Credit: University of Texas at Austin
The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal
Science, researchers at The University of Texas at Austin describe the finding, which represents good news for designing the next generation of vaccines to protect against variants of the virus or future emerging coronaviruses.
Posted: May 02, 2021 6:00 AM NT | Last Updated: May 2 comments
Jason McLellan in his lab at the University of Texas at Austin in February 2020. Many of the COVID vaccines that have been developed used Dr. McLellan’s research. (College of Natural Sciences, University of Texas at Austin)
This column is an instalment in our series
, in which cultural historian Ainsley Hawthorn examines the issues of COVID-19 through the lens of the past.
Past pandemics can bring our experiences with COVID-19 into focus, whether by reassuring us that we re far from the first people to face a serious outbreak or by showing us how similarly our ancestors reacted to the threat of illness.
The Atlantic
One Vaccine to Rule Them All
What if a single vaccine could protect us against SARS, MERS, COVID-19, and every other coronavirus-related disease, forever and ever?
Getty / Adam Maida / The Atlantic
The pandemic is at its worst, globally, and expert eyes are trained on the role of new variants. Catastrophic surges are tearing across places where some thought the darkest days were already over. In India, where hospitals are running out of oxygen and COVID-19 cases are increasing exponentially, officials are concerned about a “double mutant” version of SARS-CoV-2 called B.1.167. In Brazil, where more than 2,500 people are dying every day, the government is urging people not to get pregnant for fear of variants like P.1. And such variants are giving rise to further variants, as mutations layer on mutations.